Jeffrey Young Insider Profile

4 Followers
Jeffrey Young, CFO at Tempest Therapeutics, holds 53.75K shares in Tempest Therapeutics (Ticker: TPST), holds ― shares in Columbia Laboratories (Ticker: CBRX), holds 25.00K shares in Harvard Apparatus Regenerative Technology (Ticker: HRGN).
tipranks
Jeffrey Young

Jeffrey Young
Tempest Therapeutics (TPST)
CFO

Ranked #86,055 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-43.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$145K
59.55%
40.45%
0.00%
A breakdown of Jeffrey Young's holdings

Insider Roles

Harvard Apparatus Regenerative Technology
(HRGN)
Director
Tempest Therapeutics
(TPST)
CFO
Columbia Laboratories
(CBRX)
Chief Financial Officer
Roles that Jeffrey Young holds in companies

Most Profitable Insider Trade

Stock:
Harvard Apparatus Regenerative Technology
(HRGN)
Rating:Informative Buy
Date:Oct 02, 2019 - Oct 02, 2020
Return:-30.40%
The most profitable trade made by Jeffrey Young

Jeffrey Young's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tempest Therapeutics
Dec 07, 2015
CFO
Uninformative Buy
$58.59K
Columbia Laboratories
Chief Financial Officer
JNP
Juniper Pharmaceuticals
Aug 15, 2018
Uninformative Sell
349.75K
$0.00
Harvard Apparatus Regenerative Technology
Oct 02, 2019
Director
Informative Buy
50.00K
$86.25K
~CRTX
Cornerstone Therapeutics Inc
List of latest transactions for each holding click on a transaction to see Jeffrey Young's performance on stock

Jeffrey Young insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Young?
The percentage of profitable transactions made by Jeffrey Young is 0%.
    What is the average return per transaction made by Jeffrey Young?
    The average return per transaction made by Jeffrey Young is -43.40%.
      What stocks does Jeffrey Young hold?
      Jeffrey Young holds: TPST, CBRX, JNP, HRGN, ~CRTX stocks.
        What was Jeffrey Young’s latest transaction?
        Jeffrey Young latest transaction was an Uninformative Buy of ―.
          What was Jeffrey Young's most profitable transaction?
          Jeffrey Young’s most profitable transaction was an Informative Buy of HRGN stock on October 2, 2019. The return on the trade was -30.40%.
            What is Jeffrey Young's role in Tempest Therapeutics?
            Jeffrey Young's role in Tempest Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.